Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0RO8H
|
|||
| Former ID |
DIB004103
|
|||
| Drug Name |
AC-262271
|
|||
| Synonyms |
IOP lowering (glaucoma), Allergan; Muscarinic M1 agonists (pain, glaucoma), ACADIA/Allergan
Click to Show/Hide
|
|||
| Indication | Glaucoma/ocular hypertension [ICD-11: 9C61; ICD-9: 365] | Phase 1 | [1] | |
| Company |
Acadia pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800033965) | |||
| REF 2 | Phase I clinical trial of muscarinic agonist (AC-262271) for treating glaucoma. Acadia Pharmaceuticals. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.